Aryl Hydrocarbon Receptor Ligands Found in Cigarette Smoke Drive Pancreatic Cancer Via Pro-Tumorigenic T Cell Polarization

被引:0
|
作者
Griffith, Brian D. [1 ]
Kadiyala, Padma [2 ]
Mcgue, Jake [1 ]
Sun, Lei [1 ]
Kumar, Aadith [1 ]
Espinoza, Carlos [1 ]
Edwards, Jacob [1 ]
Donahue, Katelyn [3 ]
Zhang, Yaqing [1 ]
Cho, Clifford S. [1 ]
di Magliano, Marina Pasca [1 ,4 ]
Frankel, Timothy [1 ,5 ]
机构
[1] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Immunol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Canc Biol Program, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Cell Biol, Ann Arbor, MI 48109 USA
[5] Ann Arbor Vet Affairs Healthcare Syst, Dept Surg, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P30
引用
收藏
页码:S61 / S61
页数:1
相关论文
共 43 条
  • [41] Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways
    Therachiyil, Lubna
    Krishnankutty, Roopesh
    Ahmad, Fareed
    Mateo, Jericha M.
    Uddin, Shahab
    Korashy, Hesham M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [42] (Z)-2-(3,4-Dichlorophenyl)-3-(1H-Pyrrol-2-yl)Acrylonitrile Exhibits Selective Antitumor Activity in Breast Cancer Cell Lines via the Aryl Hydrocarbon Receptor Pathway
    Gilbert, Jayne
    De Iuliis, Geoffry N.
    Tarleton, Mark
    McCluskey, Adam
    Sakoff, Jennette A.
    MOLECULAR PHARMACOLOGY, 2018, 93 (02) : 168 - 177
  • [43] IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model
    Lutz, Veronika
    Hellmund, Veronique M.
    Picard, Felix S. R.
    Raifer, Hartmann
    Ruckenbrod, Teresa
    Klein, Matthias
    Bopp, Tobias
    Savai, Rajkumar
    Duewell, Peter
    Keber, Corinna U.
    Weigert, Andreas
    Chung, Ho-Ryun
    Buchholz, Malte
    Menke, Andre
    Gress, Thomas M.
    Huber, Magdalena
    Bauer, Christian
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (04) : 421 - 434